27.9 C
Vientiane
Monday, September 15, 2025
spot_img
Home Blog Page 13

Laos Signs Agreement to Develop Pumped-Storage Hydropower Project in Sekong

On 1 September 2025, Électricité du Laos Generation Public Company (EDL-Gen) signed an agreement with private firms from Singapore to develop a pumped-storage hydropower (PSH) project in Sekong province, Southern Laso. (Photo credit: EDL-Generation Public Company)

On 1 September, Électricité du Laos Generation Public Company (EDL-Gen) signed an agreement with private firms from Singapore to develop the pumped-storage hydropower (PSH) project.

According to EDL-Gen, the partnership will explore opportunities to boost electricity generation efficiency and ensure long-term grid stability.

Pumped-storage hydropower, which stores and releases energy by moving water between reservoirs at different elevations, is recognized globally as a proven technology to stabilize renewable energy systems by balancing intermittent sources such as wind and solar.

This is not EDL-Gen’s first step toward pumped storage. 

On 20 May, the company signed an agreement with PSG Corporation to explore retrofitting existing hydropower plants of EDL and its affiliates into pumped-storage hydropower facilities, as well as integrating solar and wind projects. That feasibility study will take two years to complete, according to state media.

Earlier, in October 2024, Laos and France signed an agreement to study a pumped-storage project near the Nam Theun 2 Hydropower Plant in Khammouane Province. With a planned capacity of up to 2,000 megawatts (MW) of storage, it would rank among the world’s ten largest pumped hydro energy storage systems, according to the French electricity company.

The existing Nam Theun 2 Hydropower Plant, one of Laos’ most significant energy projects, has a capacity of 1,075 MW and began commercial operations in 2010. It diverts water from the Nam Theun River to the Xe Bang Fai River to generate electricity, largely for export to Thailand.

In addition, Laos is advancing innovative mixed clean energy projects. 

The development of the Nam E-Moun 1 and 2 complex projects in Sekong Province, agreed in September 2023, will combine regular hydropower , pumped-storage hydropower , and floating solar panels . With an estimated investment of USD 450 million, the project remains in the feasibility stage as of September 2025.

Globally, pumped-storage hydropower has been deployed for decades as a backbone of energy security. China operates the world’s largest PSH capacity, with hubs in  Japan and the United States, where the world’s most powerful pumped hydro facility is located.

TikTok shop releases 2025 3 Fall Fashion Trends!

NEW YORK, Sept. 12, 2025 /PRNewswire/ — This Fall/Winter Fashion Week, we’re unveiling three key fashion trends from TikTok Shop. Centered on versatility, comfort, and ease, the trends — #CityTrek, #CloudComfort, and #365Core — embody our vision of fashion that is practical, comfortable, and adaptable for everyday life.

#CityTrek


Trend Concept: From subway stations to skyline views, this trend blurs the lines between commuting and exploring, city life and a life of adventure. Sleek layers and functional details deliver an urban look built for style on-the-go.

If consumers bring this trend into their daily lives, it is likely to appear in the following three scenarios.

Urban Commuter-Explorer

Weather-ready layers form comfortable-yet-protective armor—keeping commuters ready for whatever the day throws their way, from cab rides to hiking trails.

Parkside Mode

Urban leisure, simplified. Practical vests and cargo pants turn any bench or café patio into a fashion moment made easy.

Micro-Adventure Getaway

City-to-country outdoor wear. Windproof, quick-drying, and ruggedly stylish, this aesthetic is built for short hikes, weekend rides, and spontaneous escapes.

#CloudComfort


Trend Concept: Fusing comfort with professionalism for the hybrid era, #CloudComfort achieves a balance of style and coziness. Soft, flexible layers move with ease—whether lounging, working, or socializing — to stay presentable, relaxed, and seamlessly styled all day.

Under this trend, there are three key styling scenarios to inspire your creativity:

Home Chic

Loose knits, relaxed basics, and on-trend loungewear keep one cozy yet polished for spontaneous calls from the big screen to the medium screen.

Workplace Ease

Polished meets practical with soft textiles and smart tailoring that lets the wearer move through meetings with comfort and confidence.

Travel in Comfort

Lightweight fabrics (like breathable knits, natural linen, and light-as-air cotton) and loose tailoring keep trendy travelers looking sharp from takeoff to touchdown.

#365Core 


Trend Concept: A masterclass in simplicity and style, #365Core celebrates the art of “less is more” with seasonless, adaptable wardrobe staples. Thoughtfully curated essentials move across seasons, occasions, and looks—every piece versatile, practical, and timeless. 

Here are four styling scenarios for #365Core:

Stealth Edge

Luxe basics—classic suits, premium leather, crafted shoes—grow finer with age, becoming timeless wardrobe assets that embody enduring style.

Effortless Days

Soft tees, knit cardigans, and relaxed sweats mark style that’s put-together without trying. Think comfort and ease meets casual chic.

All-Season Play

One piece, endless possibilities. Layer, mix, or wear alone—core wardrobe essentials that work for every season are the ultimate style flex.

Smart Move

Core pieces form a strong foundation for urban commuting with versatile-yet-refine structured shirts, blazers, and straight-leg trousers.

Fashion Brand URBAN REVIVO Continues its Global Strategic Expansion with New London Flagship at Westfield Stratford City

LONDON, Sept. 12, 2025 /PRNewswire/ — Following the successful opening of its Covent Garden store, global fashion innovator URBAN REVIVO (UR) today strengthened its London presence with the landmark opening of its Westfield Stratford City flagship. Spanning almost 2,700m², the new store is one of UR’s largest retail spaces worldwide and an exciting addition to its over 400 stores globally.

UR’s expansive store at Westfield Stratford City, London.
UR’s expansive store at Westfield Stratford City, London.

A Spacious Store Houses Apparel that Embraces Local Aesthetics

Established in 2006, UR strives to bring high-quality fashion to all, blending the creativity and luxury of high-end labels with the accessibility and vibrancy of everyday wear. The expansive new store provides an artistically-minded space for the brand’s collections of womenswear, menswear and accessories.

Putting a stylish spin on apparel for everyday occasions, UR is committed to infusing its designs with local flair. As such, the new store features a signature British-inspired series blending tailored silhouettes with contemporary craftsmanship. Central to this global strategy is the London Design Centre, driving a substantial portion of the designs available at the new store.

The new store brings UR’s “urban revitalization” philosophy to life through impactful three-dimensional storytelling. A 12-meter kinetic façade integrates LED technology with structural glass, while industrial steel beams interlock with terracotta bricks, creating tactile tension between precision engineering and artisanal warmth. An iconic UR Prism installation transforms through daylight and artificial illumination, casting kaleidoscopic patterns that embody UR’s fusion of Eastern craftsmanship and Western futurism.

“We are thrilled to be bringing UR’s signature style to this iconic shopping location, bringing our unique and creative approach to another key mall” said Leo Li, CEO of URBAN REVIVO. “We are grateful to our partners who have facilitated this opening, especially Westfield Stratford City for bringing to brand to such a prominent position. We believe this opening is another major milestone in our development and are looking forward to a bright future here and across the region.”


 

The new store brings UR’s "urban revitalization" philosophy to life through impactful three-dimensional storytelling.
The new store brings UR’s “urban revitalization” philosophy to life through impactful three-dimensional storytelling.

Ongoing Expansion into More International Cities

UR’s new store at Westfield Stratford City builds on UR’s momentum in London, following the opening of the debut Covent Garden branch. The store is situated alongside some of the world’s best-known luxury brands, signaling UR’s confidence in competing at fashion’s forefront while creating a blueprint for future growth corridors across the region.

This latest expansion builds on the brand’s 400 stores globally. It continues UR’s established multi-flagship strategy which it has implemented around Asian hubs such as Bangkok, Hong Kong and Kuala Lumpur, where clustered premium locations have helped strengthen brand authority and consumer reach.

About URBAN REVIVO

Founded in 2006, URBAN REVIVO (UR) is a global live fashion brand that strives to elevate affordable high fashion by offering creative, high-quality, sustainable designs. With over 400 stores in China, Singapore, Malaysia, Thailand, Vietnam and the Philippines, and an extensive online network in Europe, North America, and beyond, URBAN REVIVO ensures the highest standards through advanced supply chain management and technology. The brand’s mission is to make high-quality fashion accessible to everyone and to become the world’s most influential fashion brand.

 

Bearloon Emerges as Singapore’s Leading One-Stop Shop for Gifts, Balloons, and Party Decor

With a full spectrum of services from hampers to event decoration, Bearloon simplifies celebration planning for every occasion.

SINGAPORE, Sept. 12, 2025 /PRNewswire/ — Bearloon is redefining how Singaporeans plan and celebrate life’s special moments by offering a complete suite of gifting and event solutions under one roof. From elegantly curated gift hampers and bespoke floral arrangements to eye-catching balloon installations, bouncy castles, and full-scale event styling, Bearloon is making party preparation easier and more memorable than ever.

The company’s all-in-one approach is designed for busy individuals and organisations seeking high-quality, creative celebration solutions without the stress of juggling multiple vendors. Whether it’s a birthday bash, a baby shower, or a large-scale corporate function, Bearloon ensures every detail is handled with precision and flair.

What sets Bearloon apart is its blend of creativity, convenience, and quality products all while providing competitive pricing. Customers benefit from quick turnaround times, meticulous attention to detail, and a passionate team dedicated to transforming visions into reality. The brand’s mission is simple yet powerful—make celebrations beautiful, stress-free, and gifting effortless.

At Bearloon, we believe planning should be as fun as the celebration itself, said a Bearloon spokesperson. Our one-stop service ensures our customers can find everything they need—beautifully designed, conveniently delivered.

With its rapidly expanding portfolio of services and a growing list of satisfied clients, Bearloon is poised to continue leading the market as Singapore’s go-to celebration specialist.

ABOUT BEARLOON

Bearloon is Singapore’s go-to destination for gifts, party decor, and celebration essentials. As a one-stop shop, it offers a wide range of services including customised balloons, fresh flowers, hampers, event decoration, and bouncy castles. With a reputation for speedy service, competitive pricing, and the country’s only free balloon delivery, Bearloon delivers memorable moments with convenience and flair. Learn more at https://bearloonsg.com/.

Media Contact:

Name:

Jason Peh

Email:

business@bearloonsg.com

Organization:

Bearloon Singapore Pte. Ltd.

Address:

3 New industrial road, Kimly building #03-01 536197

Phone:

+65 8383 3104

Website:

https://bearloonsg.com/

 

Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig

NANJING, China, Sept. 12, 2025 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced the first patient has been successfully dosed in a Phase 1b/II clinical trial (NCT07099430) evaluating Opamtistomig (LBL-024, PD-L1/4-1BB bispecific antibody) as monotherapy or in combination with other agents for the ‌first-line treatment of advanced melanoma‌‌.

Opamtistomig‌, a uniquely designed PD-L1/4-1BB bispecific antibody that simultaneously blocks PD-1/L1-mediated immune suppression and enhances 4-1BB-regulated T-cell activation. This dual mechanism has the potential to convert “cold tumors” into “hot tumors”, overcoming resistance to immunotherapy and improving response rates in hard-to-treat cancers.

In two prior clinical trials, Opamtistomig demonstrated promising efficacy and a favorable safety profile in patients with highly malignant, immune-cold extrapulmonary neuroendocrine carcinoma (EP-NEC), both as monotherapy and in combination with chemotherapy. Notably, patient enrollment was completed in August 2025 for a pivotal single-arm registration trial evaluating Opamtistomig monotherapy in EP-NEC.

In addition, multiple Phase 1b/II studies are ongoing to assess Opamtistomig combined with chemotherapy for:

  • First-line small cell lung cancer (SCLC)‌
  • ‌First-and second-line non-small cell lung cancer (NSCLC)

This newly initiated Phase 1b/II multicenter trial, led by Professor Chen Yu from Fujian Cancer Hospital, with participation from multiple hospitals, aims to evaluate Opamtistomig’s efficacy and safety in advanced melanoma as monotherapy or in combination regimens.

Dr. Charles Cai, Chief Medical Officer of Leads Biolabs, stated:

“The continued clinical advancement of Opamtistomig in EP-NEC and other tumor types highlights its unique ability to activate T cells while releasing immune suppression, offering hope to patients with immune-cold tumors who have limited treatment options. With more than 10 indications currently targeted across nine clinical trials, we are committed to accelerating development and delivering breakthrough therapies that expand the benefits of immunotherapy to more patients worldwide.”

About Opamtistomig

Opamtistomig (LBL-024) is a potential first-in-class bispecific antibody simultaneously targeting PD-L1 and the co-stimulatory receptor 4-1BB. It is the first 4-1BB-targeting bispecific antibody globally to reach the single arm pivotal trial stage as a monotherapy and holds promise to become the first approved treatment specifically for extrapulmonary neuroendocrine carcinoma (EP-NEC), a malignancy with significant unmet medical need.

Developed using Leads Biolabs’ proprietary X-Body™ bispecific platform, Opamtistomig features a 2:2 format with two binding domains each for PD-L1 and 4-1BB, and an optimized affinity ratio. This design allows Opamtistomig to both reverse PD-L1–mediated immune suppression and selectively enhance T cell activation, resulting in potent, synergistic anti-tumor effects.

In two clinical trials in China, Opamtistomig has demonstrated promising efficacy and a favorable safety profile in patients with advanced EP-NEC, both as monotherapy and in combination with chemotherapy. The lack of a standard of care in EP-NEC supports the pursuit of accelerated approval through a single-arm pivotal study.

In recognition of its clinical potential, Opamtistomig received Breakthrough Therapy Designation (BTD) from the National Medical Products Administration (NMPA) in China (October 2024), and Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for neuroendocrine carcinoma (November 2024).

Notably, 4-1BB agonism can reactivate exhausted T cells and drive robust proliferation, making it particularly promising for PD-1/PD-L1-resistant or immunologically “cold” tumors. Beyond EP-NEC, Opamtistomig has been approved for clinical trials across multiple cancer types with high unmet need, including small cell lung cancer (SCLC), biliary tract cancer (BTC), ovarian cancer (OC), non-small cell lung cancer (NSCLC), esophageal squamous cell carcinoma (ESCC), hepatocellular carcinoma (HCC), gastric cancer (GC), triple-negative breast cancer (TNBC), and malignant melanoma. Encouraging clinical activity has already been observed in SCLC, BTC, OC, and other cancer types, supporting Opamtistomig’s potential as a broad-spectrum oncology therapy.

About Melanoma

Melanoma is a highly aggressive and life-threatening cutaneous malignancy, ranking as the third most common type of skin cancer. Although it represents only about 5% of all skin cancers, melanoma accounts for approximately 65% of skin cancer–related deaths.

Recent advances in immunotherapy—particularly PD-1/L1 and CTLA-4 inhibitors—have expanded treatment options and improved outcomes for many patients. However, melanoma epidemiology in China differs significantly from that of Western populations, with a predominance of acral and mucosal subtypes, which are considered “immunologically cold tumors.”

Current immunotherapies, including PD-1/L1 and CTLA-4 inhibitors, show limited efficacy in these subtypes, with objective response rates (ORR) typically below 15%. Toripalimab, the only domestically developed PD-1 inhibitor approved as first-line therapy for Chinese melanoma patients, demonstrated an ORR of 11% and a median progression-free survival (PFS) of 2.3 months in registrational studies that primarily enrolled patients with acral and mucosal melanoma.

These data highlight a critical unmet medical need for more effective therapies for melanoma patients in China, particularly for those with acral and mucosal subtypes.

About Leads Biolabs

Founded in 2012, Leads Biolabs is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies to address underserved medical needs in oncology, autoimmune, and other severe diseases both in China and globally.

We are a front-runner in next-generation immuno-oncology treatments with a differentiated pipeline of 14 innovative drug candidates, including six clinical-stage drug candidates, of which four lead products are among the top-tier clinically advanced candidates globally.

We adopt a science-driven R&D approach and have successfully established comprehensive R&D capabilities spanning antibody discovery and engineering, in vivo and in vitro efficacy evaluation, as well as druggability assessment. We have also developed multiple proprietary technology platforms, including LeadsBody™ platform (a CD3 T-cell engager platform), X-body™ platform (a 4-1BB engager platform), TOPiKinectics™ (ADC platform), which serve as the cornerstone for our continued innovation and have been validated by the clinical outcomes of our bispecific antibody portfolios.

We have established integrated capabilities across early discovery, translational medicine, clinical development, CMC and business development. The innovative nature and competitive strengths of our drug candidates, coupled with our global perspectives, proactive strategy, and efficient clinical validation, have made us an attractive partner for leading industry players and venture capitals. For more information, please visit https://en.leadsbiolabs.com/

Vehere Elevates Sanjay Bhardwaj to Managing Director, India and ASEAN

SINGAPORE, Sept. 12, 2025 /PRNewswire/ — Vehere, a leader in AI-powered Cyber Network Intelligence, proudly announces the promotion of Sanjay Bhardwaj from Vice President – Sales to Managing Director, India and ASEAN, effective immediately.

Sanjay Bhardwaj, Managing Director, India and ASEAN
Sanjay Bhardwaj, Managing Director, India and ASEAN

In his new role, Sanjay will spearhead Vehere’s strategic growth initiatives and regional operations across India and the ASEAN markets. Over the past three and a half years, he has significantly contributed to the company’s impressive trajectory, propelling growth through leadership in sales, customer success, and partnerships.

Sanjay has been instrumental in expanding Vehere’s presence and capabilities within India and Southeast Asia. With his deep industry relationships and proven leadership, we are confident he will drive further growth and innovation in the region,” said Praveen Jaiswal, Co-founder and COO, Vehere.

Sanjay brings over two decades of rich industry experience in IT and cybersecurity sales, having held leadership positions at distinguished technology firms including Forescout Technologies, McAfee, Huawei-3Com, and Wipro. His expertise spans enterprise network security, channel expansion, and business development.

I am truly honored to take on this new role and lead Vehere’s vision across India and ASEAN. With cyber threats evolving rapidly, our mission is to empower organizations with unmatched situational awareness and resilience. I look forward to strengthening our customer relationships, expanding our regional footprint, and driving innovation that makes a real difference in national and enterprise security,” said Sanjay Bhardwaj, Managing Director – India & ASEAN, Vehere.

About Vehere

Vehere is a new-age Cyber Defense software company specializing in AI-powered Cyber Network Intelligence. For over a decade, Vehere has supported counter-terror operations across defense and intelligence communities. Today, Vehere’s battle-tested Network Detection and Response (NDR) solutions are trusted by Fortune 500 enterprises and government agencies alike to protect critical infrastructure in real-time.

Media Contact:
Manthan Mukherjee
manthan.mukherjee@vehere.com

 

 

Hong Kong Lab Zentrogene Cracks Twin DNA Code; Gender Mystery Solved for Moms Worldwide


HONG KONG SAR – Media OutReach Newswire – 12 September 2025 – Zentrogene Laboratory, an international genetic testing institution based in Hong Kong (under Sanai Health Industry Group 01889.HK), announced the launch of its ‘Y Precision’ testing technology based on Next-Generation Sequencing (NGS). This locally developed innovation in Hong Kong addresses longstanding industry challenges in gender determination for twin pregnancies. It overcomes the limitations of traditional qPCR platforms, achieving the first-ever precise identification of male-female twins while significantly enhancing the accuracy of fetal cell-free DNA (cfDNA) analysis.

Illustration: IP Image Ambassador Dr.z
Illustration: IP Image Ambassador Dr.z

Traditional methods could only qualitatively detect the presence of the Y chromosome, failing to distinguish between male-male twins and male-female twins. They also lacked the capability to identify residual male cfDNA after fetal reduction procedures. Zentrogene’s NGS-based technology achieves three breakthroughs:

  1. Fetal Signal Assessment: Utilizes whole-genome SNP scanning to confirm fetal signal presence, precisely quantify fetal fraction, and determine the number of fetal signals.
  2. Contamination Identification: Differentiates between false signals (e.g., contamination-derived Y chromosome fragments) and true fetal signals.
  3. Twin Pregnancy Precision Analysis: Independently analyzes X and Y chromosome fragments to accurately distinguish male-female twins from male-male twins.

As a pioneer in Hong Kong’s genetic testing field, Zentrogene has established a global technology matrix covering pre-pregnancy, prenatal, and oncology applications through its integrated Sanger sequencing and NGS platforms. This NGS breakthrough underscores its ‘Technology-Driven Globalization’ strategy, leveraging Hong Kong’s expertise to deliver precision medical solutions worldwide. Zentrogene continues to advance genetic technology, safeguarding every family’s hopes with scientific rigor.

For details, visit:
https://www.zentrogene.com/
https://www.zentrogene.com.hk/

Official Cooperation Contacts:
Telephone: +86 18051865085 (WeChat same number)
Telegram: +855 99990026
Facebook: Zentrogene

Hashtag: #Zentrogene

The issuer is solely responsible for the content of this announcement.

Fiji Airways Celebrates Historic Win as APEX World Class 2026 Airline

NADI, Fiji, Sept. 12, 2025 /PRNewswire/ — Fiji Airways, the national carrier of Fiji and a proud member of the oneworld® alliance, has achieved a historic milestone by winning the APEX World Class Airline for 2026 Award – the most prestigious recognition in global aviation that places the airline among the Top 10 Airlines in the World.

Fiji Airways also took home the award for APEX Innovation Award for Best Inflight Food/Beverage 2026. The airline recently launched a new Pacific Rim menu, alongside on-demand Business Class dining and refreshed Economy service.

Fiji Airways is the smallest airline by fleet size ever to earn this honour, and the only airline in Oceania to be recognised. The airlines’ journey to World Class was driven by its determination to have a place on the world stage, to differentiate itself, and to prove that a small airline from a small island nation can soar with the very best.

Andre Viljoen, Managing Director and CEO of Fiji Airways, said “this recognition is a proud and historic moment for the airline and for Fiji.”

The APEX World Class Award is judged through a rigorous process that combines independent audits with global passenger feedback, measuring excellence across safety, sustainability, well-being, service, and customer experience.

In 2016, we were ranked outside the world’s Top 100 airlines. Today, through sheer grit, relentless innovation, and the unbreakable spirit of our people, we have risen to be named one of the Top 10 Airlines in the World. This recognition is not just an award, it’s about showing every Fijian, and every member of our team, that we can achieve the impossible. We are the David in a world of Goliaths – and we are winning,” said Viljoen.

Achieving this recognition required one of the most extensive transformation efforts in the airline’s history. It meant a complete overhaul of the inflight experience, procuring brand new galley and service equipment, building new supply chains for freshly sourced produce, working with local Fijian businesses and manufacturers, both small and large, and introducing an entirely new suite of premium products onboard.

Months were spent developing the Pacific Rim-inspired cuisine and redesigning every part of the service flow, while hundreds of cabin crew underwent up to two weeks of intensive training. Sixteen of the best cabin crew were selected to become World Class Trainers, completing a 10-week program before leading the training across the airline.

It was a massive undertaking that required months of preparation, dedication, and teamwork before the very first World Class flight took off”, said Viljoen.

To excel, we cannot afford to be ordinary. We need to stand out, to be unmistakably remarkable, and to create an experience so extraordinary that travellers choose Fiji Airways not just for where we fly, but for how we make them feel,” added Viljoen. “That is why we embarked on the World Class journey. It required us to lift every part of our airline to a standard that only the world’s best achieve. It gives us a powerful point of difference that no amount of advertising and marketing can buy.

As we look ahead, Fiji Airways remains focused on constant innovation and raising the bar even higher,” said Viljoen.

This recognition cements Fiji Airways’ place among the world’s top 10 leaders in hospitality and excellence and shines a global spotlight on Fiji as a premier travel destination.

—ENDS—

About Fiji Airways: Founded in 1951, the Fiji Airways airline group comprises Fiji Airways, Fiji’s international airline, and its wholly-owned domestic and regional subsidiary, Fiji Link. From its hubs at Nadi and Suva International Airports, Fiji Airways and Fiji Link serve 101 destinations in over 14 countries (including code-share). Destinations include Fiji, Australia, New Zealand, the US, Canada, the UK, Hong Kong (SAR China), Singapore, India, Japan, Mainland China, Samoa, Tonga, Tuvalu, Kiribati, Vanuatu and Solomon Islands. The Fiji Airways Group brings in 70 percent of all visitors who fly to Fiji, employs over 2000 employees, and earned revenues of over FJD$1.7 billion (USD $770m) in 2023. Fiji Airways rebranded from Air Pacific in June 2013. Visit www.fijiairways.com for more information.